Champions Oncology CSBR
NASDAQ CSBR
$5.08 +0.13 (+2.63%)
At close: Sep 17, 2026 · 4:00 PM EDT

Champions Oncology (CSBR) Minority Interest (2011 - 2026)

Champions Oncology's (CSBR) quarterly Minority Interest came in at $567000.0 in Q3 2026, up 1790.0% year-over-year from $30000.0 in Q3 2025, and up 339.53% on a QoQ basis from $129000.0 in Q2 2026.

Analysis

Champions Oncology (CSBR) Minority Interest (2011 - 2026) Analysis & Trends

Champions Oncology (CSBR) has 5 years of Minority Interest data on file, last reported at $567000.0 in Q3 2026.

  • On a quarterly basis, Minority Interest rose 1790.0% year-over-year to $567000.0 in Q3 2026; TTM through Jul 2026 was $567000.0, a 1790.0% increase from a year earlier, with the FY2026 full-year figure at $129000.0, changed N/A from the prior year.
  • Minority Interest for Q3 2026 stood at $567000.0, up from $129000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at $567000.0 in Q3 2026 and bottomed at $30000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 567,000.00
Apr 30, 2026 129,000.00
Jan 31, 2026 95,000.00
Oct 31, 2025 61,000.00
Jul 31, 2025 30,000.00
Oct 31, 2013 16.88 Mn
Jul 31, 2013 16.88 Mn
Apr 30, 2013 16.88 Mn
Jan 31, 2013 16.94 Mn
Oct 31, 2012 8.16 Mn
Jul 31, 2012 8.16 Mn
Apr 30, 2012 8.16 Mn
Jan 31, 2012 8.16 Mn
Oct 31, 2011 8.16 Mn
Jul 31, 2011 8.16 Mn
Apr 30, 2011 8.16 Mn